HPV vaccine for genital warts and cervical cancer
ثبت نشده
چکیده
Those rumors are true! In 2006, the Food and Drug Administration [2] (FDA) approved the first vaccine (Gardasil) that protects against certain strains of human papillomavirus (HPV). Over 100 strands of HPV have been identified, and at least 40 strands can affect the genitals. Two strains, HPV-6 and HPV-11, are responsible for approximately 90 percent of genital warts. Two other strains, HPV-16 and HPV-18, cause approximately 66 percent of cases of cervical cancer. Though these vaccines (of which there are three available in the United States) are a great tool in preventing HPV-related disease, it?s good to know that they do NOT cure HPV.
منابع مشابه
Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
BACKGROUND Infection with HPV 16 and 18, the major causative agents of cervical cancer, can be prevented through vaccination with a bivalent or quadrivalent vaccine. Both vaccines provide cross-protection against HPV-types not included in the vaccines. In particular, the bivalent vaccine provides additional protection against HPV 31, 33, and 45 and the quadrivalent vaccine against HPV31. The qu...
متن کاملIntent to receive an HPV vaccine among university men and women and implications for vaccine administration.
OBJECTIVE AND PARTICIPANTS In 2006, the authors examined intention to receive an HPV vaccine among 340 college students. METHODS A total of 138 men and 202 women completed questionnaires. The authors measured intention by asking participants how likely they would be to accept an HPV vaccine that prevented against (1) all HPV, (2) cervical cancer but not genital warts, (3) genital warts but no...
متن کاملQuadrivalent human papillomavirus vaccine.
The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection causes >550,000 cases of cervical and anogenital cancer worldwide annually. Infection also causes precancerous lesions and genital warts. HPV types 16 and 18 cause approximately 70% of HPV-related cancers, and HPV types 6 and 11 cause approximately 90% of cases of genital warts. A quadrivalent vaccine for HPV t...
متن کاملDeveloping an HPV vaccine to prevent cervical cancer and genital warts.
The challenges of the journey from target identification through development of a prophylactic quadrivalent human papillomavirus (HPV) vaccine have been met in Gardasil. Cervical cancer is the second leading cause of cancer-related death in women worldwide. Approximately 70% of cervical cancer is caused by infection with HPV types 16 and 18 and approximately 90% of genital warts are caused by H...
متن کاملHuman papillomavirus, genital warts, and vaccines.
Human papillomavirus (HPV)-related diseases, including cancers, low-grade neoplasia, genital warts, and recurrent respiratory papillomatosis, have a substantial impact on public health. The increasing incidence of HPV infection and genital warts highlights the need for an effective strategy for the management of this disease. Immunization holds the promise of reducing the overall burden of clin...
متن کاملHPV vaccine for genital warts and cervical cancer
Those rumors are true! In 2006, the Food and Drug Administration [2] (FDA) approved the first vaccine (Gardasil) that protects against certain strains of human papillomavirus (HPV). Over 100 strands of HPV have been identified, and at least 40 strands can affect the genitals. Two strains, HPV-6 and HPV-11, are responsible for approximately 90 percent of genital warts. Two other strains, HPV-16 ...
متن کامل